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  Letter to Editor/Carta ao Editor
Neurocysticercosis: a new trend in 
SUDEP research?
Neurocisticercose: uma nova tendência em 
pesquisas de SUDEP?
Fulvio Alexandre Scorza1, Ricardo Mario Arida2, 
Philipe Ribeiro Furtado de Mendonça1, Esper Abrão 
Cavalheiro1 and João Pereira Leite3
Dear Editor:
Epilepsies constitute one of the most common serious brain 
disorders and have no geographic, social, or racial boundaries; they 
occur in men and women and affect people of all ages, although 
more frequently affecting young people in the first 2 decades of life 
and people aged >60 years. Worldwide, there are at least 50 million 
people who have epilepsy, and many of these have seizures that are 
refractory to treatment with the currently available therapies1. From 
all of the effects of the epilepsies, perhaps the most concerning is 
sudden unexpected death in epilepsy (SUDEP).
Unfortunately, very little progress has been made in preventing 
the occurrence of SUDEP and, in addition, SUDEP is rarely discussed 
among neurologists and scientists. As we know, ~1 in 1,000 patients 
with chronic epilepsy will die suddenly, unexpectedly, and without 
explanation each year2. Furthermore, epilepsy is associated with a 
2- to 3-fold increase in mortality compared to the general population, 
and SUDEP is the most important direct epilepsy-related cause of 
death3. To date, a wide range of factors for SUDEP have been assessed, 
including refractoriness of the epileptic condition, occurrence 
of generalized tonic-clonic seizures, antiepileptic medication 
(polytherapy with antiepileptic drugs), young age, duration of the 
seizure disorder, early onset of epilepsy, and winter temperatures4. 
Knowledge of the risk factors underlying SUDEP could guide 
investigations into its pathophysiologic mechanisms5. In this context, 
understanding the mechanisms underlying SUDEP may lead to the 
identification of previously unrecognized risk factors that are more 
amenable to correction6. Although different mechanisms may play 
separate roles in different cases, the 2 major domains that are involved 
in SUDEP are autonomic, i.e., cardiovascular, and respiratory6. 
In brief, respiratory compromise, such as increased lung weight, 
pulmonary congestion, or edema, appears frequently in postmortem 
examinations of SUDEP victims5. From a cardiovascular point of 
view, it is very probable that cardiac changes during and between 
seizures play a potential role in SUDEP4.
In recent years, significant progress has been made in identifying 
some of the associated risk factors for SUDEP, the clearest of which 
are uncontrolled epilepsy and a history of generalized tonic-clonic 
seizures6. Conversely, it is important to note that it remains to be 
elucidated which factors make an individual more susceptible to 
this outcome than another with comparable epilepsy severity. 
Following this reasoning, a very interesting recent paper, reporting 
a case of SUDEP in a patient with a solitary cysticercosis lesion 
in the cerebral cortex7, inspired us to propose a new hypothesis 
concerning SUDEP. Approximately 40 million people who have 
epilepsy live in countries with poor resources, and the major cause 
of this higher rate of epilepsy is related to the presence of endemic 
parasitic diseases such as neurocysticercosis (NCy). The clinical 
features of NCy are sufficiently well recognized and may present 
with almost any neurological manifestation. An enormous number 
of case reports have described every possible sign or symptom; 
however, the vast majority of cases present as either headaches (due 
to intracranial hypertension) or seizure disorders. Classically, NCy is 
a major contributor to the burden of seizures and acquired epilepsy 
in developing countries but is also becoming a health concern in 
developed countries8. For example, in the United States, Wallin and 
Kurtzke showed that over the past 2 decades, NCy was found in 10% 
of patients who had seizures and were evaluated in an emergency 
department in Los Angeles and in 6% of patients in New Mexico, 
qualifying NCy as an important emerging infection9. The treatment 
modality available to individuals with NCy for preventing or 
decreasing the severity and number of seizures is anti-epileptic drugs. 
To our knowledge, there are very few reports describing the 
association between sudden death and NCy10–12. For example, in 
1997, Ndhlovu described a case of sudden death that turned out 
to be an unexpected case of NCy. The author calls attention to the 
fact that most doctors expect cerebral NCy to present with seizures 
and have forgotten its other clinical manifestations10. Verma and 
colleagues reported a rare case of sudden death in an apparently 
healthy asymptomatic young adult male who was involved in a 
vehicular accident and died almost instantaneously due to the rupture 
of cysticerci cysts during trauma11. More recently, Llompart Pou 
and coworkers reported an acute case of a native woman from Peru 
who had cephalalgia that rapidly worsened and caused sudden and 
unexpected death12. In brief, the authors reported that the patient 
came to the emergency room complaining of severe headache for 
the previous 6h. On arrival, she acted strangely, although no seizure 
activity was noted and she had not been taking medication. She was 
placed under observation, and almost 2h later she presented with 
cardiorespiratory arrest and died after 20 min of cardiopulmonary 
resuscitation12.
Considering the facts described above, the major question now 
is whether there is any possible relationship between NCy and the 
occurrence of SUDEP. As exact knowledge regarding this association 
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is lacking, some possibilities could be evaluated. Considering that 
NCy is a major cause of acquired epilepsy in Latin American countries 
and that the main risk factors for SUDEP are associated with poorly 
controlled seizures, our research group is in agreement with Professor 
Natasha Holmes and colleagues in proposing that because of the 
high prevalence of seizures in NCy, SUDEP may also play a large 
role in this disease7. Overall, experimental, epidemiological, and 
clinical studies will help in precise evaluation of the possible and 
real association between NCy, seizure occurrence, and SUDEP. For 
future studies, we suggest increased efforts, mainly in countries where 
NCy is endemic, in order to correlate the clinical, morphological, 
and physiological features of NCy patients who suffered SUDEP. In 
conclusion and despite some progress, SUDEP remains a significant 
clinical problem. Unfortunately, as all of the risk factors, mechanisms, 
and specific methods for preventing SUDEP have not been identified, 
exercising caution is prudent and necessary.
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